switchpointbio-com / rounds / 2026-03-10
status=sourced json
| announced | 2026-03-10 | D |
|---|---|---|
| amount | 5,270,0005.3M USD | D |
| lead | null | D |
| participants | null | D |
| previous | null |
| person | role | side | src |
|---|---|---|---|
| David Proctor | Director | company | D |
| Jussi Paananen | Director, Executive Officer | company | D |
| Samuel Myllykangas | Director, Executive Officer | company | D |
| a | tie | b | since | src |
|---|---|---|---|---|
| David Proctor | BOARD SwitchPoint Bio Holding, Inc. | Jussi Paananen | null | D |
| David Proctor |
| WORKED_WITH SwitchPoint Bio Holding, Inc. |
| Jussi Paananen |
| 2026 |
| D |
| David Proctor | BOARD SwitchPoint Bio Holding, Inc. | Samuel Myllykangas | null | D |
| David Proctor | WORKED_WITH SwitchPoint Bio Holding, Inc. | Samuel Myllykangas | 2026 | D |
| Jussi Paananen | BOARD SwitchPoint Bio Holding, Inc. | Samuel Myllykangas | null | D |
| Jussi Paananen | WORKED_WITH SwitchPoint Bio Holding, Inc. | Samuel Myllykangas | 2026 | D |